Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors. [PDF]
Sherman SK +5 more
europepmc +1 more source
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study [PDF]
Murray, CDR +8 more
core
Design of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity. [PDF]
Vishnoi S +3 more
europepmc +1 more source
Beyond weight loss: Preserving muscle health in the incretin era
Journal of Diabetes Investigation, Volume 17, Issue 10, Page 1658-1661, October 2026.
Toshinori Imaizumi, Daisuke Yabe
wiley +1 more source
Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes. [PDF]
Piraccini BM +4 more
europepmc +1 more source
Recent advances in incretin biology and therapeutics: From glucose-dependent insulinotropic polypeptide reappraisal to next-generation agonists. [PDF]
Kubota S, Seino Y, Yabe D.
europepmc +1 more source
Specific Collagen Peptides Support Postprandial Metabolic Health by Modulating Incretin Hormones, Gastric Transit, and Glycemic Control in Participants with Normoglycemia and Prediabetes. [PDF]
Virgilio N +7 more
europepmc +1 more source
Tail-Suspension Model of Simulated Microgravity-Induced Functional Dyspepsia in Rats: Behavioral, Motility, and Brain-Gut Peptide Alterations. [PDF]
Li W +6 more
europepmc +1 more source
Clinical Potential of GIP in Type 2 Diabetes and Obesity. [PDF]
Nauck M +4 more
europepmc +1 more source
Oestrogen modulates stress-induced vagally-dependent gastric responses to oxytocin. [PDF]
Bhagat R, Travagli RA, Browning KN.
europepmc +1 more source

